|
|
| 0.05 Data as of Dec 05 |  0.00 / 0.00%Today’s Change | 0.04 Today|||52-Week Range 0.20 | -69.51% Year-to-Date |
| Previous close | 0.05 |
| Today’s open | 0.04 |
| Day’s range | -- - -- |
| Volume | 101,850 |
| Average volume (3 months) | 102,208 |
| Market cap | $18.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +50.00% |
| Earnings growth (this year) | +51.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -19.45% |
| P/E ratio | NM |
| Price/Sales | 7.74 |
| Price/Book | 3.02 |
| Today’s change | Today’s % change | |
|---|---|---|
| GALTUGalectin Therapeutic... | +2.73 | +13.67% |
| TROVUTrovagene Inc | 0.00 | 0.00% |
| FPMIFluoroPharma Medical... | 0.00 | 0.00% |
| BMRABiomerica Inc | 0.00 | 0.00% |
| Next reporting date | March 26, 2014 |
| EPS forecast (this quarter) | -$0.00 |
| Annual revenue (last year) | $7.6M |
| Annual profit (last year) | -$2.2M |
| Net profit margin | -29.40% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Steve T. Laflin |
Chief Financial Officer & Secretary Laurie A. McKenzie-Carter |
Corporate headquarters Idaho Falls, Idaho |
.
